November 14, 2008 - The 21st annual International Symposium on Endovascular Therapy (ISET) will bring together industry leaders and experts to deliver cutting-edge interventional education to meet the needs of physicians Jan.18-22 at the Westin Diplomat Resort and Spa in Hollywood, FL.

November 14, 2008 - Royal Philips Electronics said the cardiovascular X-ray business of its healthcare division was recently recognized as the No. 1 vendor in the Cardiovascular /Interventional Radiology X-ray Study category by KLAS, an independent research firm specializing in monitoring and reporting performance of healthcare medical equipment, software, and professional services vendors.

KLAS said the Philips Allura Xper FD20 technology ranked first in overall performance in the cardiovascular/interventional radiology X-ray study, published in August 2008.

November 14, 2008 - A stent that entices artery-lining cells to coat it works as well, or better than, drug-eluting stents (DES) in keeping arteries open in coronary heart disease patients, according to two research studies presented this week at the American Heart Association's Scientific Sessions 2008 in New Orleans.

November 14, 2008 – Overall, in patients with a common form of non-STEMI there is not a significant difference in the combined endpoint of death, heart attack or stroke at six months whether their diagnostic angiogram is performed within 24 hours of the non-STEMI or days later, according to research released at AHA 2008 this week.

November 13, 2008 - Based on its recent analysis of the drug eluting-stents (DES) market, Frost & Sullivan today recognized Boston Scientific with the 2008 North American Frost & Sullivan Market Leadership Award, highlighting important milestones for Boston Scientific, including FDA approvals for the PROMUS Everolimus-Eluting Coronary Stent System, the TAXUS Express2, Atom Stent, and the company's second-generation TAXUS Liberte Stent.